0K9H.LSE Faes Farma SA
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 0.04%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2023.
Is 0K9H.LSE undervalued?
Graham numberThe Graham number of Faes Farma SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Faes Farma SA fundamental analysis
No fundamental analysis for Faes Farma SA yet.
Faes Farma SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using…
Full company profileFaes Farma SA financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Faes Farma SA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 229M | 275M | 324M | 357M | 380M | - | - | - |
| Gross Profit | 151M | 178M | 204M | 227M | 240M | - | - | - |
| Operating Income | 45.9M | 50.6M | 62.0M | 74.9M | 86.8M | - | - | - |
| Net Income | 36.6M | 41.4M | 51.6M | 64.0M | 72.5M | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 331M | 430M | 471M | 494M | 564M | - | - | - |
| Total Liabilities | 46.3M | 110M | 111M | 80.7M | 92.8M | - | - | - |
| Shareholders' Equity | 285M | 320M | 360M | 413M | 471M | - | - | - |
| Cash & Short-term Investments | 66.0M | 43.3M | 76.4M | 54.2M | 93.1M | - | - | - |
| Total Debt | 1.19M | 43.1M | 885K | 3.18M | 1.65M | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 49.6M | 41.7M | 59.3M | 67.6M | 78.5M | 79.6M | 107M | - |
| Capital Expenditure | 12.0M | 16.6M | 12.7M | 17.0M | 20.2M | 51.5M | 75.2M | 0.00 |
| Ratios | ||||||||
| ROE | 12.8% | 13.0% | 14.3% | 15.5% | 15.4% | - | - | - |
| ROA | 11.0% | 9.6% | 10.9% | 13.0% | 12.9% | - | - | - |
| Net Profit Margin | 16.0% | 15.1% | 15.9% | 17.9% | 19.1% | - | - | - |
| Debt to Equity | 0.00x | 0.13x | 0.00x | 0.01x | 0.00x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Faes Farma SA dividends
Faes Farma SA has not paid dividends in the last 9 fiscal years.
Last stock split: 1.02:1 on Apr 7, 2015.
Who owns Faes Farma SA
- Insiders 20.35%
- Institutions 15.76%
- Public & others 63.89%
- Free float 218M
Faes Farma SA company profile
- Company name
- Faes Farma SA
- Ticker
- 0K9H.LSE
- ISIN
- ES0134950F36
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 2,677
- Fiscal year end
- December
- Address
- Avenida AutonomIa 10, Leioa, Spain, 48940
- Phone
- 34 944 81 83 00
- Website
- faesfarma.com
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
Faes Farma SA management
10- Mr. Eduardo Recoder de la CuadraCEO & Executive Director
- Mr. Iker Etxezarreta FraileChief Financial Officer
- Ms. Isabel NajeraChief Scientific & Medical Officer
- Ms. Maria MarinHead of Investor Relations & External Communication
- Mr. Alberto Fernández FernándezChief Marketing & Portfolio Strategy Officer
- Mr. Carlos Gutierrez AgueroChief People Officer
- Mr. Xavier ArnaudChief Business Development Officer
- Mr. Jose Luis Diaz CapoteChief International Business Officer
- Ms. Mariana Soroa ZubiriaChief GRC & Internal Audit Officer
- Mr. German Fernandez-CanodíazChief Farm Faes Business Officer